Uroš Markovic

417 total citations
36 papers, 188 citations indexed

About

Uroš Markovic is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Uroš Markovic has authored 36 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 14 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Uroš Markovic's work include Multiple Myeloma Research and Treatments (11 papers), Protein Degradation and Inhibitors (7 papers) and Platelet Disorders and Treatments (5 papers). Uroš Markovic is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Protein Degradation and Inhibitors (7 papers) and Platelet Disorders and Treatments (5 papers). Uroš Markovic collaborates with scholars based in Italy, Czechia and United Kingdom. Uroš Markovic's co-authors include Francesco Di Raimondo, Gaetano Giuffrida, Alessandra Romano, Salvatore Leotta, Concetta Conticello, Andrea Duminuco, Giuseppe A. Palumbo, Daniele Tibullo, Vittorio Del Fabro and Valeria Calafiore and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Uroš Markovic

31 papers receiving 183 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Uroš Markovic Italy	8	95	60	41	33	32	36	188
Jong‐Mi Lee South Korea	9	104 1.1×	55 0.9×	44 1.1×	32 1.0×	77 2.4×	30	246
Qiaochuan Li China	10	129 1.4×	110 1.8×	48 1.2×	53 1.6×	49 1.5×	32	296
Marco Fossati Italy	9	69 0.7×	46 0.8×	86 2.1×	36 1.1×	92 2.9×	22	264
Francisco J. Márquez‐Malaver Spain	9	171 1.8×	47 0.8×	68 1.7×	39 1.2×	44 1.4×	21	266
Masakatsu Yanagimachi Japan	9	60 0.6×	51 0.8×	38 0.9×	15 0.5×	73 2.3×	15	225
Cheryl Goss United States	7	87 0.9×	21 0.3×	29 0.7×	51 1.5×	10 0.3×	15	187
Rosane Bittencourt Brazil	10	163 1.7×	102 1.7×	71 1.7×	34 1.0×	23 0.7×	39	238
Juan Manuel Alonso‐Domínguez Spain	10	106 1.1×	78 1.3×	58 1.4×	75 2.3×	30 0.9×	40	242
Sara Boyce United Kingdom	7	107 1.1×	68 1.1×	46 1.1×	12 0.4×	15 0.5×	16	214
Blanca Boluda Spain	9	104 1.1×	56 0.9×	103 2.5×	19 0.6×	17 0.5×	32	250

Countries citing papers authored by Uroš Markovic

Since Specialization

Citations

This map shows the geographic impact of Uroš Markovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uroš Markovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uroš Markovic more than expected).

Fields of papers citing papers by Uroš Markovic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uroš Markovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uroš Markovic. The network helps show where Uroš Markovic may publish in the future.

Co-authorship network of co-authors of Uroš Markovic

This figure shows the co-authorship network connecting the top 25 collaborators of Uroš Markovic. A scholar is included among the top collaborators of Uroš Markovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uroš Markovic. Uroš Markovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Duminuco, Andrea, Patrick Harrington, Vittorio Del Fabro, et al.. (2025). Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape. Pharmaceuticals. 18(8). 1212–1212. 1 indexed citations

Stagno, Fabio, Stefania Stella, Salvatore Leotta, et al.. (2025). No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level. International Journal of Molecular Sciences. 26(5). 1840–1840.

Vetro, Calogero, Uroš Markovic, Andrea Duminuco, et al.. (2023). A case of high‐risk AML in a patient with advanced systemic mastocytosis. SHILAP Revista de lepidopterología. 11(7). e7134–e7134. 4 indexed citations

Fabro, Vittorio Del, Andrea Duminuco, Uroš Markovic, et al.. (2023). Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study. Cancers. 15(16). 4036–4036. 3 indexed citations

Fabro, Vittorio Del, Nunziatina Laura Parrinello, Alessandro Allegra, et al.. (2023). Multiple Myeloma in 2023 Ways: From Trials to Real Life. Current Oncology. 30(11). 9710–9733. 8 indexed citations

Duminuco, Andrea, L. Gullo, Valeria Calafiore, et al.. (2023). Effectiveness and Safety of Eliglustat Treatment in Gaucher Disease: Real-life Unicentric Experience. Clinical Therapeutics. 45(11). 1105–1110. 3 indexed citations

Giuffrida, Gaetano, et al.. (2023). Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review. Orphanet Journal of Rare Diseases. 18(1). 27–27. 24 indexed citations

Duminuco, Andrea, Uroš Markovic, Nunziatina Laura Parrinello, et al.. (2023). Potential clinical impact of T-cell lymphocyte kinetics monitoring in patients with B cell precursors acute lymphoblastic leukemia treated with blinatumomab: a single-center experience. Frontiers in Immunology. 14. 1195734–1195734. 2 indexed citations

Castorina, P., et al.. (2022). Combination of Interleukin-6, C-Reactive Protein and Procalcitonin Values as Predictive Index of Sepsis in Course of Fever Episode in Adult Haematological Patients: Observational and Statistical Study. Journal of Clinical Medicine. 11(22). 6800–6800. 10 indexed citations

10.

Romano, Alessandra, Claudio Cerchione, Concetta Conticello, et al.. (2022). Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection. Cancers. 14(5). 1173–1173. 3 indexed citations

11.

Duminuco, Andrea, et al.. (2022). Acquired hemophilia A following COVID-19 vaccination – The importance of prompt diagnosis: A case report. Transfusion and Apheresis Science. 62(2). 103577–103577. 5 indexed citations

12.

Leotta, Salvatore, Andrea Duminuco, Antonino Mulè, et al.. (2022). Minimal Residual Disease Negativity after Blinatumomab Is Predictive of Survival in B-Cell Acute Lymphoblastic Leukemia: Data from a Real-Life Study. Blood. 140(Supplement 1). 11854–11855. 1 indexed citations

13.

Markovic, Uroš, Alessandra Romano, Vittorio Del Fabro, et al.. (2021). Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey. Frontiers in Oncology. 11. 624405–624405. 7 indexed citations

14.

Markovic, Uroš, et al.. (2021). Immune thrombocytopenic purpura cases following COVID-19 vaccination.. Mediterranean Journal of Hematology and Infectious Diseases. 13(1). e2021047–e2021047. 7 indexed citations

15.

Markovic, Uroš, et al.. (2021). A Treatment-free Interval Allowed by Ponatinib as Fourth-line Therapy. Cancer Diagnosis & Prognosis. 1(1). 19–22. 1 indexed citations

16.

Giuffrida, Gaetano, et al.. (2021). Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine. Haematologica. 107(4). 1008–1010. 13 indexed citations

17.

Milone, Giuseppe, Concetta Conticello, Salvatore Leotta, et al.. (2020). Plerixafor on-demand in association with low-dose cyclophosphamide and G-CSF in the mobilization of patients with multiple myeloma: High effectiveness, low toxicity, and affordable cost. Leukemia Research Reports. 14. 100227–100227. 4 indexed citations

18.

Markovic, Uroš, Salvatore Leotta, Stefania Stella, et al.. (2020). Second-line Dasatinib Therapy Improved Compliance and Deep Molecular Responses in Imatinib-intolerant Chronic Myeloid Leukemia Patients. Anticancer Research. 40(9). 5313–5317. 5 indexed citations

19.

Leotta, Salvatore, Giuseppe Sapienza, Uroš Markovic, et al.. (2020). Preliminary Results of a Combined Score Based on sIL2-Rα and TIM-3 Levels Assayed Early After Hematopoietic Transplantation. Frontiers in Immunology. 10. 3158–3158. 7 indexed citations

20.

Markovic, Uroš, Valeria Calafiore, Enrica Antonia Martino, et al.. (2019). A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones?. SHILAP Revista de lepidopterología. 7(9). 1629–1636. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact